Mechanism of action and selective toxicity of ascamycin, a nucleoside antibiotic.

AUTOR(ES)

Osada, H

RESUMO

An unidentified Streptomyces sp. produces two nucleoside antibiotics, ascamycin and its dealanyl derivative. In contrast to the broad antibacterial activity of dealanylascamycin against various gram-negative and gram-positive bacteria, ascamycin showed selective toxicity against Xanthomonas citri and X. oryzae. Both ascamycin and dealanylascamycin inhibited the protein synthesis of X. citri, but only dealanylascamycin inhibited that of Escherichia coli. In cell-free systems from E. coli and X. citri, both antibiotics, at ca. 0.04 micrograms/ml, inhibited the polyuridylate-directed synthesis of polyphenylalanine by ca. 50%. These data suggest that ascamycin cannot permeate the bacterial membrane. The dealanylating activity toward ascamycin was found only on the cell surface of bacteria susceptible to ascamycin. Dealanylascamycin must then have been transported into cytoplasm, where it inhibited protein synthesis.

Documentos Relacionados

• Mechanism of action of cinodine, a glycocinnamoylspermidine antibiotic.
• Mechanism of action of habekacin, a novel amino acid-containing aminoglycoside antibiotic.
• In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic.
• Naphthyridinomycin, a DNA-reactive antibiotic.
• Mechanism of the antibiotic action pyocyanine.